88 related articles for article (PubMed ID: 1694539)
21. Neuron-specific enolase in small-cell carcinoma of the lung: the value of combined immunocytochemistry and serum determination.
Esscher T; Bergh J; Steinholtz L; Nöu E; Nilsson K; Påhlman S
Anticancer Res; 1989; 9(6):1717-20. PubMed ID: 2560624
[TBL] [Abstract][Full Text] [Related]
22. Gastric metastasis and ectopic amylase production in bronchogenic carcinoma.
Bhasin DK; Kochhar R; Nagi B; Malik SK; Mehta SK
J Assoc Physicians India; 1989 Apr; 37(4):289-90. PubMed ID: 2482288
[TBL] [Abstract][Full Text] [Related]
23. [Shortness of breath, sensation of pressure at the thorax and languor (thoracic radiography, urinary and serum amylase levels): (amylase-producing primary lung cancer) (adenocarcinoma)].
Kasagi A; Yokoyama M; Natsuisaka T; Tatsuno S
Nihon Rinsho; 1977; 35 Suppl 2():3074-5, 3438-9. PubMed ID: 611238
[No Abstract] [Full Text] [Related]
24. Changes in cell characteristics due to culture conditions in cell lines from human small cell lung cancer.
Terasaki T; Shimosato Y; Nakajima T; Tsumuraya M; Morinaga S; Hirohashi S; Yamaguchi K; Kato K; Ichinose H; Nagatsu T
Jpn J Clin Oncol; 1986 Sep; 16(3):203-12. PubMed ID: 3022030
[TBL] [Abstract][Full Text] [Related]
25. [Bronchofiberscopy and pathologic findings in small cell lung cancer].
Hu HC
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Feb; 8(1):31-3, 61-2. PubMed ID: 2986919
[No Abstract] [Full Text] [Related]
26. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
Gu C; Oyama T; Osaki T; Kohno K; Yasumoto K
Anticancer Res; 2001; 21(4A):2357-62. PubMed ID: 11724293
[TBL] [Abstract][Full Text] [Related]
27. [Serum neuron-specific enolase in patients with lung cancer].
Matsubara Y; Yasuda Y; Yagi K; Ike O; Aoki M; Miyamoto Y; Hatakenaka R; Ninomiya K; Funatsu T; Ikeda S
Nihon Gan Chiryo Gakkai Shi; 1985 Jul; 20(6):1136-45. PubMed ID: 2999271
[No Abstract] [Full Text] [Related]
28. [A case of lung cancer producing CA19-9 and amylase].
Takano Y; Iwakiri T; Ichiyasu Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):267-70. PubMed ID: 7685838
[TBL] [Abstract][Full Text] [Related]
29. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
30. The histopathological and immunohistochemical diagnosis in small cell lung carcinoma.
Dragan AM; Simu G; Vaida T
Rom J Morphol Embryol; 1999-2004; 45():91-5. PubMed ID: 15847383
[TBL] [Abstract][Full Text] [Related]
31. [Bronchoscopic findings of small cell lung cancer].
Ono R; Ikeda S
Nihon Gan Chiryo Gakkai Shi; 1988 Dec; 23(11):2663-8. PubMed ID: 2854835
[No Abstract] [Full Text] [Related]
32. Telomerase activity in endoscopically visible lung cancer.
Hirashima T; Yoshitaka O; Nitta T; Sasada S; Kobayashi M; Masuda N; Matsui K; Nakagawa K; Yasumitsu T; Takada Y; Kikui M; Kawase I
Anticancer Res; 2001; 21(5):3685-9. PubMed ID: 11848543
[TBL] [Abstract][Full Text] [Related]
33. Expression of deltaNp73 predicts poor prognosis in lung cancer.
Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Morita M; Funa K; Yasumoto K
Clin Cancer Res; 2004 Oct; 10(20):6905-11. PubMed ID: 15501968
[TBL] [Abstract][Full Text] [Related]
34. [Differential lung cancer diagnosis--progress or fiasco?].
Müller KM
Fortschr Med; 1990 Apr; 108(11):17-9. PubMed ID: 2162802
[No Abstract] [Full Text] [Related]
35. [Amylase producing tumor].
Yamamoto H; Kuroda R
Ryoikibetsu Shokogun Shirizu; 1994; (4):17-9. PubMed ID: 7516440
[No Abstract] [Full Text] [Related]
36. Expression of histidine decarboxylase and synthesis of histamine by human small cell lung carcinoma.
Graff L; Frungieri M; Zanner R; Pohlinger A; Prinz C; Gratzl M
Am J Pathol; 2002 May; 160(5):1561-5. PubMed ID: 12000707
[TBL] [Abstract][Full Text] [Related]
37. Auditing a new lung cancer service.
Cullen JP; Glynn C; Murtagh E; Hogan B; Jeffers M; Lane SJ
Ir Med J; 2004 Oct; 97(9):281-3. PubMed ID: 15568588
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung.
Bobos M; Hytiroglou P; Kostopoulos I; Karkavelas G; Papadimitriou CS
Am J Dermatopathol; 2006 Apr; 28(2):99-104. PubMed ID: 16625069
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical markers of prolonged survival in small cell carcinoma of the lung. An immunohistochemical study.
Sloman A; D'Amico F; Yousem SA
Arch Pathol Lab Med; 1996 May; 120(5):465-72. PubMed ID: 8639050
[TBL] [Abstract][Full Text] [Related]
40. Comparison of DNA topoisomerase II alpha expression in small cell and nonsmall cell carcinoma of the lung. In search of a mechanism of chemotherapeutic response.
Guinee DG; Holden JA; Benfield JR; Woodward ML; Przygodzki RM; Fishback NF; Koss MN; Travis WD
Cancer; 1996 Aug; 78(4):729-35. PubMed ID: 8756364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
